COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a population-based case-control study in St. Petersburg, Russia
View ORCID ProfileAnton Barchuk, View ORCID ProfileAnna Bulina, View ORCID ProfileMikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, View ORCID ProfileOksana Stanevich, Dmitriy Skougarevskiy, Artemiy Okhotin
doi: https://doi.org/10.1101/2022.01.24.22269714
Anton Barchuk
1Institute for Interdisciplinary Health Research, European University at St. Petersburg, Shpalernaya Ulitsa 1, St. Petersburg, Russia, 191187
5NN Petrov National Research Medical Centre of Oncology, Pesochny, Leningradskaya Ulitsa 68, St. Petersburg, Russia, 197758
6Health Sciences, Faculty of Social Sciences, Tampere University, Arvo Ylpön katu 34, Tampere, Finland, 33520
Anna Bulina
1Institute for Interdisciplinary Health Research, European University at St. Petersburg, Shpalernaya Ulitsa 1, St. Petersburg, Russia, 191187
Mikhail Cherkashin
2Medical Institute named after Berezin Sergey, Esenina Ulitsa 2-3a, St. Petersburg, Russia, 194354
Natalia Berezina
2Medical Institute named after Berezin Sergey, Esenina Ulitsa 2-3a, St. Petersburg, Russia, 194354
Tatyana Rakova
2Medical Institute named after Berezin Sergey, Esenina Ulitsa 2-3a, St. Petersburg, Russia, 194354
Darya Kuplevatskaya
2Medical Institute named after Berezin Sergey, Esenina Ulitsa 2-3a, St. Petersburg, Russia, 194354
Oksana Stanevich
1Institute for Interdisciplinary Health Research, European University at St. Petersburg, Shpalernaya Ulitsa 1, St. Petersburg, Russia, 191187
4ITMO University, St. Petersburg, Russia, 197101
Dmitriy Skougarevskiy
1Institute for Interdisciplinary Health Research, European University at St. Petersburg, Shpalernaya Ulitsa 1, St. Petersburg, Russia, 191187
Artemiy Okhotin
3Tarusa Hospital, Karla Libknekhta Ulitsa 16, Tarusa, Russia, 249100
4ITMO University, St. Petersburg, Russia, 197101
Data Availability
Study data and code is available online.
Posted May 02, 2022.
COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a population-based case-control study in St. Petersburg, Russia
Anton Barchuk, Anna Bulina, Mikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Oksana Stanevich, Dmitriy Skougarevskiy, Artemiy Okhotin
medRxiv 2022.01.24.22269714; doi: https://doi.org/10.1101/2022.01.24.22269714
COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a population-based case-control study in St. Petersburg, Russia
Anton Barchuk, Anna Bulina, Mikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Oksana Stanevich, Dmitriy Skougarevskiy, Artemiy Okhotin
medRxiv 2022.01.24.22269714; doi: https://doi.org/10.1101/2022.01.24.22269714
Subject Area
Subject Areas
- Addiction Medicine (365)
- Allergy and Immunology (685)
- Anesthesia (184)
- Cardiovascular Medicine (2727)
- Dermatology (234)
- Emergency Medicine (411)
- Epidemiology (12378)
- Forensic Medicine (10)
- Gastroenterology (783)
- Genetic and Genomic Medicine (4236)
- Geriatric Medicine (394)
- Health Economics (698)
- Health Informatics (2736)
- Health Policy (1015)
- Hematology (369)
- HIV/AIDS (874)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (450)
- Neurology (4014)
- Nursing (216)
- Nutrition (594)
- Oncology (2114)
- Ophthalmology (603)
- Orthopedics (251)
- Otolaryngology (310)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1145)
- Primary Care Research (465)
- Public and Global Health (6632)
- Radiology and Imaging (1441)
- Respiratory Medicine (883)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (462)
- Toxicology (57)
- Transplantation (192)
- Urology (171)